PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Pantaflix AG (PAL.DE)
1.170.00 (0.00%)
1.17 - 1.17
1.10 - 1.60
166 / 2.1K (Avg.)
-9.00 | -0.13
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-58.30%
Negative revenue growth while PGN.DE stands at 26.91%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-131.27%
Negative gross profit growth while PGN.DE is at 32.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-103.92%
Negative EBIT growth while PGN.DE is at 526.20%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-103.92%
Negative operating income growth while PGN.DE is at 496.77%. Joel Greenblatt would press for urgent turnaround measures.
-107.05%
Negative net income growth while PGN.DE stands at 109450.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-107.03%
Negative EPS growth while PGN.DE is at 95900.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-107.03%
Negative diluted EPS growth while PGN.DE is at 95900.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.60%
Negative 10Y revenue/share CAGR while PGN.DE stands at 23.92%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-16.60%
Negative 5Y CAGR while PGN.DE stands at 23.92%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-16.60%
Negative 3Y CAGR while PGN.DE stands at 17.38%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-114.11%
Negative 10Y net income/share CAGR while PGN.DE is at 173.91%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-114.11%
Negative 5Y net income/share CAGR while PGN.DE is 173.91%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-114.11%
Negative 3Y CAGR while PGN.DE is 75.34%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.32%
We cut SG&A while PGN.DE invests at 11.65%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.